An RNA drug can hit its target and still cause trouble elsewhere. Deep Genomics is building AI that reads both sides of that bargain, with laboratory experiments keeping score.

A Yale computer scientist turned gene lists into sentences, then carried the idea from an academic lab into a startup. The bet behind CellType is plain enough to say and difficult enough to occupy a career: biology can become a language machines learn to predict.